The International Contrast Ultrasound Society (ICUS)

Dr. Fabio Piscaglia Elected to ICUS Board

CHICAGO -- Dr. Fabio Piscaglia, of Bologna, Italy, has been elected to the Board of Directors of the International Contrast Ultrasound Society (ICUS), the world’s only medical professional society exclusively focused on the use of contrast-enhanced ultrasound (CEUS) imaging to improve patient care worldwide. ICUS members include radiologists, gastro-enterologists, cardiologists, and other medical imaging professionals and scientists from 58 countries.

Dr. Piscaglia will serve as one of two European representatives to the ICUS Board. He replaces Dr. David Cosgrove, of London, who now serves as secretary of ICUS. The other ICUS Board representataive for Europe is Dr. Mark Monaghan, also of London.

Dr. Piscaglia heads the Center for Ultrasound in Internal Medicine at the University of Bologna. He is an internationally-recognized expert in the use of ultrasound and CEUS to detect and evaluate liver tumors and other abnormalities, and frequently publishes and lectures in the field. He also is president-elect of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB), served as general secretary of the 2000 congress of the World Federation of Ultrasound in Medicine and Biology (WFUMB), and is a peer reviewer for more than 15 scientific journals. Dr. Piscaglia also organized the Euroson School on CEUS in Liver, Biliary, Pancreatic and Gastrointestinal Disease and has been appointed director of the Clinical School in Liver Imaging of the European Society for the Study of the Liver for 2012. He also serves on the Editorial Board of Ultraschall / European Journal of Ultrasound.

CEUS is a form of ultrasound imaging that uses contrast agents to improve the accuracy and reliability of standard ultrasound images. CEUS does not expose patients to ionizing radiation and does not require catheterization -- two potential drawbacks of SPECT nuclear imaging and angiography. In addition, ultrasound contrast agents do not contain dye.

Ultrasound contrast agents are routinely used throughout Europe, Canada, Asia and South America for detecting and monitoring disease and tumors throughout the body. However, in the United States, ultrasound contrast agents are only FDA-approved for certain types of cardiac imaging; additional applications are under review.

“CEUS can offer a safe and cost effective means of improving the accuracy of ultrasound diagnoses, spotting tumors and other abnormalities, and monitoring treatment,” according to Dr. Barry Goldberg, Co-president of ICUS and Director of Diagnostic Ultrasound at Thomas Jefferson University Hospital in Philadelphia. Dr. Goldberg said that CEUS has a favorable safety profile and can reduce overall health care costs, since improved ultrasound images often make additional downstream diagnostic testing unnecessary in some patients.

“Professor Piscaglia is an excellent scientist and excellent clinician, comes up with clear questions and statements, and last but not least is a charming Italian gentleman,” according to Dr. Kurt Jaeger, Vice President of ICUS for Vasicular Imaging and Head of the Department of Vascular Medicine at University Hospital in Basel, Switzerland. Dr. Jaeger said that European physicians have routinely used CEUS for more than a decade, and a majority of CEUS examinations performed throughout Europe, including Italy, are performed by gastroenterologists and internists who have “a tremendous amount of experience and have produced a high quality scientific papers.”

“I am honored by this position and I will do my best to contribute the work of ICUS,” Dr. Piscaglia said.

“We consider our Board and our members to be valuable resources, advocates and educators,” according to Dr. Goldberg.

Additional ICUS Board members are: Co-President -- Dr. Steven Feinstein (US); Vice Presidents -- Dr. Stephanie Wilson (Calgary, Canada) and Dr. Petros Nihoyannopoulos (London); Treasurer -- Dr. Michael Main (US); and Board Members -- Dr. Shintaro Beppu (Japan), Dr. Wilson Mathias (Brazil), Dr. Paul Grayburn (US), Dr. Fuminori Moriyasu (Japan), Dr. Maria Cristina Chammas (Brazil), Dr. Brian Fowlkes (US), and Dr. Lennard Greenbaum (US).

ICUS Sponsors

ICUS gratefully acknowledges its 2017 sponsors:

dentons-logo2

silver-level

Toshiba Medical logo resized

samsung-logo

siemens-new-original

philips-icus-logo

mindray

ICUS Tweets

Follow Bubble Conference 2016 comment at #bubble2016
Connect live now to the 31st Annual Advances in Contrast Ultrasound "Bubble Conference" taking place in Chicago; https://t.co/67SmoW2GLn
FDA approves new liver imaging agent for adults and children; reduces exposure to harmful radiation. More at: https://t.co/3qa1vDFFhW

Contact ICUS

  • Address: 1900 K Street, N.W.
    Washington, DC 20006-1102, USA
  • Telephone: 202-408-6199

About ICUS

ICUS is the world’s only professional society exclusively devoted to contrast-enhanced ultrasound (CEUS) medical imaging technology.

Learn more...

You are here: Home ICUS News Dr. Fabio Piscaglia Elected to ICUS Board